logo

Compass Therapeutics Inc (CMPX) Stock: The Story of a 52-Week Stock Range

CSCO Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Compass Therapeutics Inc’s current trading price is -13.85% away from its 52-week high, while its distance from the 52-week low is 163.53%. The stock’s price range for this period has been between $0.76 and $2.34 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.21 million for the day, a number notably higher than the average daily volume of 0.48 million over the last three months.

Compass Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $2.34 on 03/15/24, while the lowest value for the same period was recorded at $0.76 on 07/05/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Compass Therapeutics Inc (CMPX) has experienced a quarterly rise of 16.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 277.38M and boasts a workforce of 32 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.6068, with a change in price of +0.6225. Similarly, Compass Therapeutics Inc recorded 463,602 in trading volume during the last 100 days, posting a change of +53.66%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CMPX stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.05.

CMPX Stock Stochastic Average

Compass Therapeutics Inc’s raw stochastic average for the past 50 days is presently 70.21%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 94.27%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 56.25% and 45.46%, respectively.

CMPX Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 39.03%.However, over the last six months, we can see a weaker performance of 111.74%. Over the last 30 days, the price of CMPX has fallen by 21.45%. And in the last five days, it has surged by 39.03%.

Most Popular